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We assessed morbidity due to Opisthorchis viverrini and
Schistosoma mekongi infections in 243 individuals in Lao
People’s Democratic Republic. Morbidity was associated
with O. viverrini infection intensity. Coinfection with S.
mekongi resulted in excess risk of liver ﬁbrosis and left liver
lobe enlargement. The high public health impact of opis-
thorchiasis warrants control.
Food-borne trematodiasis is of public health importance in
Southeast Asia [1]. More than 8 million people are parasitized
by the liver ﬂuke Opisthorchis viverrini, and an estimated
76 000 individuals have severe clinical manifestation, causing
a global burden of 70 000 disability-adjusted life-years [2].
Opisthorchis viverrini infection is associated with hepatobiliary
morbidity, such as hepatomegaly, jaundice, cholecystitis, chol-
angitis, and cholangiocarcinoma, a fatal bile duct cancer [3].
In Lao People’s Democratic Republic (PDR), >70% of the
resident population lives in areas where the prevalence of O.
viverrini exceeds 5%, and almost 2 million people are infected
[4]. The highest prevalence rates occur in central-southern Lao
PDR [5]. However, detailed information on intestinal and hep-
atobiliary morbidity due to O. viverrini infection is lacking.
Furthermore, the effect of coinfection with the blood ﬂuke
Schistosoma mekongi, endemic in the southern Champasack
province [6], has never been assessed.
Opisthorchis viverrini is acquired by consumption of insufﬁ-
ciently cooked ﬁsh dishes. The adult parasite lives and repro-
duces in bile ducts. In contrast, S. mekongi cercariae penetrate
human skin when exposed to infested water. The adult para-
site reproduces in the portal vein. Both parasites lead to hepa-
tobiliary pathologies. The most widely used diagnostic
approach is the detection of parasite eggs in stool. The objec-
tive of this study was to assess the severity of morbidity associ-
ated with O. viverrini and concurrent S. mekongi infection in
adults in Lao PDR.
METHODS
Ethics Statement
The study was approved by the Ethics Committee of Basel,
Switzerland, and the National Ethics Committee, Vientiane,
Lao PDR. Written informed consent was obtained from all
participants. Head of households signed for minors (aged <18
years). People infected with O. viverrini and/or S. mekongi
were treated with praziquantel (40 mg/kg, single oral dose).
Soil-transmitted helminth infections were treated with alben-
dazole (400 mg, single oral dose) [7]. Antispasmodic treat-
ment and oral rehydration were provided to purged patients
with abdominal pain and diarrhea.
Field and Laboratory Procedures
Cross-sectional surveys were carried out in hospitals and vil-
lages. Hospital investigations were done at the infectious
disease ward of Mahosot (largest hospital in the capital city of
Vientiane) and Savannakhet provincial hospital (referral hos-
pital for central provinces of Lao PDR) in September–October
2005. Village surveys were conducted in O. viverrini–endemic
areas in June 2006 (Champhone district, Savannakhet prov-
ince; and Saravane district, Saravane province), in
O. viverrini–S. mekongi coendemic areas (Mounlapamok and
Khong districts, Champasack province), and in an area where
neither ﬂuke infection is present (Paksong district, Champa-
sack province) between March and May 2006.
Hospital patients and villagers (aged ≥15 years) who sub-
mitted a stool sample for parasitological examination, which
revealed the presence of O. viverrini–like eggs, were selected
and invited to participate in the study. Three stool specimens
collected over a period of 5 days were subjected to the
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Kato-Katz method (single 41.7-mg-thick smear per specimen)
[8]. Helminth eggs were enumerated under a microscope and
recorded for each species separately.
The number of O. viverrini ﬂukes was quantiﬁed by purga-
tion. Study participants were treated with praziquantel (40
mg/kg) after dinner. Albendazole (400 mg) was added if the
patient was coinfected with soil-transmitted helminths. The
following morning a purgative (45 mL of monosodium-
sulphate solution, Swiff, Berlin Pharmaceutical Industry Co,
Ltd, Berlin, Germany) was administered. All stools produced
within 24 hours (usually 6–8 bowel movements) were collect-
ed and quantitatively examined for adult O. viverrini worms
(length 5.5–9.5 mm, width 0.7–1.6 mm).
Morbidity data were obtained from each participant by in-
terview (ie, right upper quadrant [RUQ] pain and abdominal
discomfort [ADC]) and by physical examination (ie, hepato-
megaly, jaundice, splenomegaly, and RUQ pain at palpation),
conducted by a general physician. Examining the level of left
liver lobe (hepatomegaly) and of spleen was done in the stand-
ing position from xiphoid to liver or spleen edge. Additionally,
an experienced radiologist performed an abdominal ultraso-
nography in all enrolled persons to assess left liver lobe en-
largement measuring from cranial to the caudal margin,
destruction surrounding intrahepatic bile duct (periductal ﬁ-
brosis), common bile duct dilatation (CBD), and intrahepatic
bile duct dilatation (IHBD). The radiologist was unaware of
stool examination results.
Statistical Analysis
Data were double-entered in EpiData (www.epidata.ch) and
analyzed using Stata software (version 10.1). Data were sum-
marized using proportions (categorical variables) and arith-
metic mean (worm counts). Negative binomial regression was
used to calculate the intensity rate ratio (IRR) and to associate
adult worms counts with the clinical indicators (presence or
absence). Multivariate logistic regressions were used to
compare clinical outcomes of noninfected individuals with
categories of infected individuals. Left liver lobe size was clas-
siﬁed into normal (size ≤2 SD) and enlarged (size >2 SD)
using height-adjusted measures from a Chinese reference pop-
ulation [9]. A P value of <.05 was considered statistically
signiﬁcant.
RESULTS
Two hundred forty-three individuals were enrolled: 15 from
hospitals, 80 from O. viverrini–endemic areas, 49 from
O. viverrini–S. mekongi coendemic areas, and 99 from an area
where neither parasite is endemic (uninfected). One hundred
twenty-three participants (50.6%) had an O. viverrini infec-
tion, whereas 21 individuals (8.6%) were concurrently infected
with O. viverrini and S. mekongi. All individuals with S.
mekongi infections were restricted to the Kong and Mounlapa-
mok districts, and they were all coinfected with O. viverrini.
There were 117 females (48.2%); median age was 38 years
(range, 15–81 years).
Most participants reported ADC (65.8%), whereas one-
third reported RUQ pain (13.6%). Upon physical examination,
jaundice was diagnosed in 9 patients (3.7%). Ultrasono-
graphy revealed CBD (4.1%), any liver ﬁbrosis (10.7%), and
gallbladder stones (7.3%). IHBD was diagnosed in 3 patients
(1.2%).
Opisthorchis viverrini infection intensity was signiﬁcantly
higher in males than in females (IRR, 1.9; 95% conﬁdence in-
terval [CI], 1.1–3.5) and increased with age (IRR, 1.2; 95% CI,
1.1–1.5). Positive associations were observed between morbidi-
ty and O. viverrini infection intensity, the latter quantiﬁed by
the number of adult O. viverrini worms after purging
(Table 1). Patients with RUQ pain (IRR, 2.6; 95% CI, 1.1–6.3),
ADC (IRR, 2.7; 95% CI, 1.4–5.2), and jaundice (IRR, 2.3; 95%
CI, 1.1–5.9) had an almost 3 times higher O. viverrini worm
burden than those without. Hepatobiliary pathology was posi-
tively associated with O. viverrini infection intensity. The
strongest association was found in patients with IHBD (IRR,
12.9; 95% CI, 5.2–20.2).
Association between morbidity and O. viverrini infection
(infected vs noninfected) and coinfection with S. mekongi
showed strong associations but distinctly different patterns.
Whereas patients with a single O. viverrini infection had a
highly increased risk for RUQ pain (odds ratio [OR], 3.6; 95%
CI, 1.5–8.3) and ADC (OR, 6.3; 95% CI, 3.4–11.5) compared
with their noninfected counterparts, patients coinfected with
O. viverrini and S. mekongi had an increased risk for liver pa-
thology. Compared with the uninfected control group, they
had an almost 12-fold (OR, 11.7; 95% CI, 4.3–31.7) and 14-
fold (OR, 13.6; 95% CI, 3.9–47.7) higher risk for liver ﬁbrosis
and left liver lobe enlargement, respectively.
DISCUSSION
This report highlights the severe intestinal and hepatobiliary
morbidity that may be associated with O. viverrini and
S. mekongi coinfection. We investigated patients from different
settings of central and southern Lao PDR and found severe
morbidity associated with O. viverrini single infection and
with O. viverrini–S. mekongi coinfection. Strikingly, the O. vi-
verrini worm burden, as determined after purging, is strongly
associated with self-reported morbidity and with clinical and
ultrasound investigations. Purging is the only direct method of
worm burden assessment, but this procedure is rarely per-
formed [10]. Hence, this investigation provides new evidence
that O. viverrini infection causes substantial morbidity in Lao
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PDR. The widespread distribution of this liver ﬂuke in Lao
PDR and in northeastern Thailand and adjacent countries of
Southeast Asia, and the high morbidity it causes, calls for con-
certed action [3, 5, 11, 12].
Ultrasonographic examinations revealed that individuals
with concurrent infections with O. viverrini and S. mekongi
were frequently diagnosed with liver ﬁbrosis and hepatomega-
ly. However, the liver ﬁbrosis frequency reported (10.7%) was
considerably lower than in the endemic area in northeast
Thailand (23.6%) [13]. Schistosoma mekongi can cause liver (eg,
advanced liver ﬁbrosis and portal hypertension) and spleen
morbidity [6]. The current study included 1 group of patients
coinfected with S. mekongi and O. viverrini. Our ﬁndings
suggest that concurrent infection with both ﬂukes aggravates
morbidity, compared with single infection, supporting earlier
reports suggesting that multiple helminth infections, even at
low-intensity levels, may elicit important morbidity [14].
In future research, it will be crucial to compare the current
ﬁndings with a patient group infected with S. mekongi alone.
Other infection factors related to hepatic morbidity, such as
viral hepatitis, might have contributed to morbidity, and this
needs further scientiﬁc inquiry.
We adhered to a rigorous diagnostic approach. Study partic-
ipants had multiple stool samples examined with the quantita-
tive Kato-Katz technique, supplemented with purging to
determine the worm burden. Usually, the number of eggs
found in the stools is taken as proxy for the number of adult
parasites. Purging allows direct counting of adult O. viverrini
worms and enables differential diagnosis with intestinal ﬂuke
infections, also prevalent in Lao PDR. We showed that
Table 1. Prevalence and Association of Morbidity With Opisthorchis viverrini Infection Intensity (Mean Worm Burden) and Infection
Status (O. viverrini Infection and Coinfection Between O. viverrini and Schistosoma mekongi) Among Study Participants (N = 243)
Indicator
Measurements
Prevalence
(N = 243) % (No.)
Intensity of Infection Association
P Value
No. of Adult O. viverrini Flukes
in Stool (N = 243) No. Infection
(n = 99)
O. viverrini
Infection
(n = 123)
O. viverrini–
S. mekongi Coinfection
(n = 21)
Mean IRR (95% CI) P Value
OR (95%
CI) OR (95% CI) OR (95% CI)
Self-report morbidity
Right upper quadrant pain
No 86.4 (210) 87 1.0 1.0 1.0 1.0
Yes 13.6 (33) 225 2.6 (1.1–6.3) .022 0.2 (.1–.6) 3.6 (1.5–8.3) 1.1 (.3–3.8) .002
Abdominal discomfort
No 34.2 (83) 50 1.0 1.0 1.0 1.0
Yes 65.8 (160) 135 2.7 (1.4–5.2) .004 0.2 (.1–.4) 6.3 (3.4–11.5) 0.5 (.2–1.3) <.001
Physical examination
Jaundice
No 96.3 (234) 103 1.0
Yes 3.7 (9) 235 2.3 (1.1–5.9) .011 NA NA NA NA
Ultrasound examination
Intrahepatic bile duct dilation
No 98.8 (240) 92 1.0
Yes 1.2 (3) 1188 12.9 (5.2–20.2) .003 NA NA NA NA
Common bile duct dilation
No 95.9 (233) 94 1.0
Yes 4.1 (10) 383 4.1 (1.1–19.1) .026 NA NA NA NA
Periductal liver fibrosis
No 89.3 (217) 87 1.0 1.0 1.0
Yes 10.7 (26) 265 3.1 (1.1–8.2) .012 0.2 (.1–.6) 0.9 (.4–2.2) 11.7 (4.3–31.7) <.001
Size of left liver lobe
Normal ≤2 SD 53.5 (130) 140 1.0 1.0 1.00 1.0
Enlarged >2 SD 46.5 (113) 67 0.5 (.3–.9) .023 0.3 (.1–.5) 1.7 (.9–2.8) 13.6 (3.9–47.7) <.001
P values were obtained from the likelihood ratio test.
Abbreviations: CI, confidence interval; IRR, intensity rate ratio calculated from negative binomial regression model; NA, not applicable; OR, odds ratio obtained
from logistic regression model; SD, standard deviation.
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substantial hepatobiliary pathologies are induced by O. viverrini
infection in Lao PDR; it is therefore conceivable that morbidi-
ty attributable to O. viverrini is currently underestimated [2].
Community-based investigations, including the assessment of
precursors of cholangiocarcinoma, are warranted. In particu-
lar, S. mekongi–induced morbidity is of importance and needs
urgent attention and public health action.
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